Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Poster Session Abstracts

Abstract P2-12-09: A randomized controlled trial of support group intervention after breast cancer treatment: Results on sick leave, health care utilization and health economy.

Björneklett H Granstam, A Rosenblad, C Lindemalm, M-L Ojutkangas, H Letocha, P Strang and L Bergkvist
Björneklett H Granstam
Centre for Clinical Research, Västerås, Västmanland, Sweden; Cancer Center Karolinska, Karolinska, Stockhoöm, Sweden; Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Rosenblad
Centre for Clinical Research, Västerås, Västmanland, Sweden; Cancer Center Karolinska, Karolinska, Stockhoöm, Sweden; Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Lindemalm
Centre for Clinical Research, Västerås, Västmanland, Sweden; Cancer Center Karolinska, Karolinska, Stockhoöm, Sweden; Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M-L Ojutkangas
Centre for Clinical Research, Västerås, Västmanland, Sweden; Cancer Center Karolinska, Karolinska, Stockhoöm, Sweden; Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Letocha
Centre for Clinical Research, Västerås, Västmanland, Sweden; Cancer Center Karolinska, Karolinska, Stockhoöm, Sweden; Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Strang
Centre for Clinical Research, Västerås, Västmanland, Sweden; Cancer Center Karolinska, Karolinska, Stockhoöm, Sweden; Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Bergkvist
Centre for Clinical Research, Västerås, Västmanland, Sweden; Cancer Center Karolinska, Karolinska, Stockhoöm, Sweden; Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/0008-5472.SABCS12-P2-12-09 Published December 2012
  • Article
  • Info & Metrics
Loading
Abstracts: Thirty-Fifth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 4‐8, 2012; San Antonio, TX

Abstract

Background: More than 50% of breast cancer patients are diagnosed before the age of 65. Returning to work after treatment is, therefore, of interest for both the individual and society. The aim was, therefore, to study the effect of support group intervention on sick leave, health care utilization and health economy.

Material and Methods: Of 382 patients with newly diagnosed breast cancer, 191 + 191 patients were randomized to an intervention group or to a routine control group respectively.

The intervention group received support intervention on a residential basis for one week, followed by four days of follow-up two months later. The support intervention included informative-educational sections, relaxation training, mental visualization and non-verbal communication. Patients answered a questionnaire at baseline, 2, 6 and 12 months about sick leave and health care utilization.

Result There was a trend towards longer sick leave and more health care utilization in the intervention group. The difference in total costs was statistically significantly higher in the intervention group after 12 months (p = 0.0036)

Conclusion There was no economic benefit from intervention in its present form. In fact we saw a tendency towards longer sick leave and more health care utilization and we could show that the total cost in the intervention group was actually higher and that this difference was statistically significant after twelve months.

Key words: Support intervention, breast cancer, return to work, sick leave, health care utilization, health economy

Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P2-12-09.

Back to top
Cancer Research: 72 (24 Supplement)
December 2012
Volume 72, Issue 24 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract P2-12-09: A randomized controlled trial of support group intervention after breast cancer treatment: Results on sick leave, health care utilization and health economy.
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract P2-12-09: A randomized controlled trial of support group intervention after breast cancer treatment: Results on sick leave, health care utilization and health economy.
Björneklett H Granstam, A Rosenblad, C Lindemalm, M-L Ojutkangas, H Letocha, P Strang and L Bergkvist
Cancer Res December 15 2012 (72) (24 Supplement) P2-12-09; DOI: 10.1158/0008-5472.SABCS12-P2-12-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract P2-12-09: A randomized controlled trial of support group intervention after breast cancer treatment: Results on sick leave, health care utilization and health economy.
Björneklett H Granstam, A Rosenblad, C Lindemalm, M-L Ojutkangas, H Letocha, P Strang and L Bergkvist
Cancer Res December 15 2012 (72) (24 Supplement) P2-12-09; DOI: 10.1158/0008-5472.SABCS12-P2-12-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Poster Session Abstracts

  • Abstract P6-14-05: Phase 2 study evaluating the efficacy and safety of eribulin mesylate administered biweekly for patients with human epidermal growth factor receptor 2-negative metastatic breast cancer
  • Abstract P6-08-07: Decline in compliance to breast cancer screening in France: Results of the 5th EDIFICE survey
  • Abstract P6-08-04: National trends in mastectomy for operable breast cancers treated with neoadjuvant chemotherapy
Show more 3

Poster Session 2 - Psychosocial, Quality of Life, and Educational Aspects: Quality of Life - Supportive Care

  • Abstract P2-12-11: Use of the DigniCap™ System to Prevent Hair Loss in Women Receiving Chemotherapy (CTX) for Stage I Breast Cancer (BC)
  • Abstract P2-12-14: Use of the MD Anderson Symptom Inventory to Screen for Depression in Breast Cancer
  • Abstract P2-12-06: Ultra-low dose vaginal estriol and Lactobacillus acidophilus (Gynoflor®) in early breast cancer survivors on aromatase inhibitors: Pharmacokinetic, efficacy and safety results from a phase I study.
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement